Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 22 matching records.
22 results — page 1 of 1
- Level DLaboratory StudyEurope PMC
Mechanistic insights of neuronal death and neuroprotective therapeutic approaches in stroke
Laboratory Study on Stroke Research, Neuroinflammation, published in Neural Regen Res (2026) — summary generated from the PubMed abstract.
- 2026
Neural Regen Res12 citations - Level DLaboratory StudyEurope PMC
Lips in health and in systemic sclerosis: relevant physiology, pathogenesis, existing therapeutic approaches and unmet needs
Laboratory Study on Autoimmune Research, published in J Scleroderma Relat Disord (2026) — summary generated from the PubMed abstract.
- 2026
J Scleroderma Relat Disord - Level DNarrative ReviewPubMed
Advances in stem cell therapy for erectile dysfunction: preclinical evidence and emerging therapeutic approaches.
Narrative Review on Systemic / IV, published in Front Med (Lausanne) (2025) — summary generated from the PubMed abstract.
- 2025
Front Med (Lausanne)5 citations - Level DNarrative ReviewEurope PMC
Erectile Dysfunction in Diabetes Mellitus: A Comprehensive Narrative Review of Pathophysiology, Genetic Association Studies and Therapeutic Approaches
Narrative Review on Systemic / IV, published in Endocrinol Diabetes Metab (2025) — summary generated from the PubMed abstract.
- 2025
Endocrinol Diabetes Metab1 citations - Level DNarrative ReviewEurope PMC
Recent approaches of antibody therapeutics in androgenetic alopecia
Narrative Review on Hair Loss, published in Front Pharmacol (2024) — summary generated from the PubMed abstract.
- 2024
Front Pharmacol7 citations - Level DNarrative ReviewPubMed
Adipose tissue senescence: Biological changes, hallmarks and therapeutic approaches.
Narrative Review on Chronic Inflammation, published in Mech Ageing Dev (2024) — summary generated from the PubMed abstract.
- 2024
Mech Ageing Dev - Level BClinical TrialEurope PMC
Therapeutic Approaches to Systemic Sclerosis: Recent Approvals and Future Candidate Therapies
Clinical Trial on Cardiovascular Disease, published in Clin Rev Allergy Immunol (2023) — summary generated from the PubMed abstract.
- 2023
Clin Rev Allergy Immunol28 citations - Level BClinical TrialEurope PMC
Control of the post-infarct immune microenvironment through biotherapeutic and biomaterial-based approaches
Clinical Trial on Cardiovascular Disease, Chronic Inflammation, Immune Modulation, published in Drug Deliv Transl Res (2023) — summary generated from the PubMed abstract.
- 2023
Drug Deliv Transl Res7 citations - Level DNarrative ReviewEurope PMC
Pharmacotherapeutic Approaches to Treatment of Muscular Dystrophies
Narrative Review on Cardiovascular Disease, Scar, Chronic Inflammation, published in Biomolecules (2023) — summary generated from the PubMed abstract.
- 2023
Biomolecules8 citations - Level DNarrative ReviewEurope PMC
Localized Perivascular Therapeutic Approaches to Inhibit Venous Neointimal Hyperplasia in Arteriovenous Fistula Access for Hemodialysis Use
Narrative Review on Chronic Kidney Disease, Autoimmune Research, published in Biomolecules (2022) — summary generated from the PubMed abstract.
- 2022
Biomolecules21 citations - Level DNarrative ReviewPubMed
COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods.
Narrative Review on Stroke Research, Neuroinflammation, published in Anticancer Agents Med Chem (2021) — summary generated from the PubMed abstract.
- 2021
Anticancer Agents Med Chem - Level DLaboratory StudyPubMed
Oxytocin may have a therapeutical potential against cardiovascular disease. Possible pharmaceutical and behavioral approaches.
Laboratory Study on Systemic / IV, published in Med Hypotheses (2020) — summary generated from the PubMed abstract.
- 2020
Med Hypotheses - Level BClinical TrialEurope PMC
Approaches to therapeutic angiogenesis for ischemic heart disease
Clinical Trial on Cardiovascular Disease, published in J Mol Med (Berl) (2019) — summary generated from the PubMed abstract.
- 2019
J Mol Med (Berl)88 citations - Level BClinical TrialEurope PMC
Stem cells in Osteoporosis: From Biology to New Therapeutic Approaches
Clinical Trial on Systemic / IV, published in Stem Cells Int (2019) — summary generated from the PubMed abstract.
- 2019
Stem Cells Int52 citations - Level BClinical TrialPubMed
Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
Clinical Trial on Immune Modulation, Autoimmune Research, published in Front Immunol (2018) — summary generated from the PubMed abstract.
- 2018
Front Immunol44 citations - Level BClinical TrialPubMed
The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts.
Clinical Trial on Chronic Wound, Immune Modulation, published in Cancer Lett (2017) — summary generated from the PubMed abstract.
- 2017
Cancer Lett - Level DNarrative ReviewEurope PMC
Human iPSC for Therapeutic Approaches to the Nervous System: Present and Future Applications
Narrative Review on Stroke Research, Spinal Cord Injury, published in Stem Cells Int (2016) — summary generated from the PubMed abstract.
- 2016
Stem Cells Int20 citations - Level DNarrative ReviewEurope PMC
Ocular Complications of Diabetes and Therapeutic Approaches
Narrative Review on Systemic / IV, published in Biomed Res Int (2016) — summary generated from the PubMed abstract.
- 2016
Biomed Res Int101 citations - Level BClinical TrialPubMed
[Adipose-derived stromal cells (ASC) - basics and therapeutic approaches in otorhinolaryngology].
Clinical Trial on Chronic Wound, Immune Modulation, published in Laryngorhinootologie (2014) — summary generated from the PubMed abstract.
- 2014
Laryngorhinootologie7 citations - Level DNarrative ReviewPubMed
Brown adipose tissue and novel therapeutic approaches to treat metabolic disorders.
Narrative Review on Type 2 Diabetes, published in Transl Res (2014) — summary generated from the PubMed abstract.
- 2014
Transl Res - Level DNarrative ReviewPubMed
Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
Narrative Review on Type 2 Diabetes, published in J Gastroenterol Hepatol (2013) — summary generated from the PubMed abstract.
- 2013
J Gastroenterol Hepatol - Level BClinical TrialPubMed
Emerging therapeutic approaches for multipotent mesenchymal stromal cells.
Clinical Trial on Immune Modulation, published in Curr Opin Hematol (2010) — summary generated from the PubMed abstract.
- 2010
Curr Opin Hematol
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406